Do telomerase antagonists represent a novel anti-cancer strategy?
1996

Do telomerase antagonists represent a novel anti-cancer strategy?

Editorial

Author Information

Author(s): EK Parkinson

Primary Institution: CRC Beatson Laboratories, Beatson Institute for Cancer Research

Hypothesis

Do telomerase antagonists represent a novel anti-cancer strategy?

Conclusion

Telomerase antagonists may provide a targeted approach to cancer therapy by specifically affecting tumor cells that rely on telomerase for survival.

Supporting Evidence

  • 85% of human cancers reactivate telomerase to become immortal.
  • Telomerase is detectable in over 80% of human tumor samples.
  • Inhibition of telomerase limits the lifespan of immortal human tumor cells.

Takeaway

This article discusses how cancer cells use a special enzyme called telomerase to keep growing, and suggests that blocking this enzyme could be a new way to treat cancer.

Limitations

The article discusses potential resistance mechanisms to telomerase antagonists and the complexity of telomere biology.

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication